Skip to content
MS
unreviewed

Ferrochelatase (FECH)

1 reactions · 1 pathways

Clinical / pharmacological. Erythropoietic protoporphyria; also inhibited by lead

What it does, reaction by reaction

1 reactions

Heme Biosynthesis (Porphyrin Pathway) Amino Acid & Nitrogen Metabolism · Mitochondrion + cytosol

step 8 Irreversible

Protoporphyrin IX + Fe²⁺ → heme (protoheme IX) + 2 H⁺

Converts Protoporphyrin IX Fe2+ into Heme (protoheme IX) H+

Notes

Ferrochelatase (FECH) inserts ferrous iron into protoporphyrin IX on the matrix side of the inner mitochondrial membrane. This final step requires bioavailable Fe²⁺ and is effectively irreversible; lead also inhibits ferrochelatase.

Showing all 1 reactions.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

1 entries

Heme Biosynthesis (Porphyrin Pathway)

Listed there as: Ferrochelatase

Accelerated by

Ferrous iron availability; intact mitochondrial iron delivery

Inhibited by

Lead; iron deficiency; FECH pathogenic variants

Hormonal control

Indirectly coupled to erythropoiesis and iron-regulatory signaling

Recent literature

Europe PMC · from cache · sorted by publication date

  1. 1
  2. 2
    From 18 F-choline to prostate-specific membrane antigen PET: lessons from early multiparametric kinetic modelling in prostate cancer.

    Haroon A, Almuhaideb A, Adeleke S, Endozo R, Erlandsson K, Syed GMS, Emberton M, Bomanji J. · 2026-05-19

    unreviewed
  3. 3
    FECH, a novel metabolic target influencing CAR T-cell phenotype and function.

    Pellegrino M, Vespa S, Salvatori I, Mac GD, Valle C, Secli V, Cairoli S, Goffredo BM, Caforio M, Folgiero V, … · 2026-08-12

    unreviewed
  4. 4
    Spatially resolved transcriptomic profiling of myelofibrosis spleen reveals compartment specific niche programs.

    Peroni E, Pizzi M, Basso M, Atanasio A, Calistri E, Gottardi M, Rosato A. · 2026-08-03

    unreviewed
  5. 5
  6. 6
    Cascade Amplification of Photoimmunotherapy via Mitochondrial Dual-Ion Interference in a Bimetallic-Organic Framework.

    Cao Z, Jiao J, Wang Q, Su H, Feng S, Zhang R, Xin R, Ma Q, Zheng N, Li K, Liu S, He L, Liu S. · 2026-07-31

    unreviewed
  7. 7
    AI-driven structure- and ligand-based discovery of novel Ferrochelatase inhibitors from heterocyclic libraries.

    Cho SC, Wang YW, Chu CA, Huang MC, Pangging M, Lee CT. · 2026-07-25

    unreviewed
  8. 8
  9. 9
    High Operating Potential Induces Conversion in Li-Rich Chalcogenides.

    Mishra A, Davis VK, Dulock NV, Patheria ES, Dalleska NF, See KA. · 2026-07-05

    unreviewed
  10. 10
    The structural chemistry and biosynthesis of chlorophylls.

    Hunter CN, Morey-Burrows FS. · 2026-06-25

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.